PPHC(PPHC)
PPHC
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $209M | $223M | $237M | $252M | $262M |
| Low | $207M | $221M | $234M | $250M | $260M |
| High | $210M | $224M | $241M | $253M | $264M |
| EBITDA Avg | $-14M | $-15M | $-16M | $-17M | $-18M |
| Low | $-14M | $-15M | $-16M | $-17M | $-18M |
| High | $-14M | $-15M | $-16M | $-17M | $-18M |
| EBIT Avg | $-26M | $-28M | $-29M | $-31M | $-32M |
| Low | $-26M | $-28M | $-30M | $-31M | $-33M |
| High | $-26M | $-27M | $-29M | $-31M | $-32M |
| Net Income Avg | $35M | $37M | $39M | $43M | $43M |
| Low | $35M | $37M | $39M | $43M | $43M |
| High | $35M | $38M | $40M | $44M | $44M |
| EPS Avg | $1.21 | $1.29 | $1.35 | $1.49 | $1.50 |
| Low | $1.20 | $1.28 | $1.34 | $1.48 | $1.49 |
| High | $1.22 | $1.31 | $1.37 | $1.51 | $1.52 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 2 | 2 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $53M | $54M |
| Low | $53M | $54M |
| High | $53M | $54M |
| EBITDA Avg | $-4M | $-4M |
| Low | $-4M | $-4M |
| High | $-4M | $-4M |
| EBIT Avg | $-7M | $-7M |
| Low | $-7M | $-7M |
| High | $-7M | $-7M |
| Net Income Avg | $8M | $8M |
| Low | $8M | $8M |
| High | $8M | $9M |
| EPS Avg | $0.32 | $0.34 |
| Low | $0.32 | $0.33 |
| High | $0.32 | $0.35 |
| Analysts (Rev / EPS) | 1 / 1 | 2 / 2 |